Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

AliExpress lĩnh án phạt kỷ lục tại EU vì hàng giả

AliExpress lĩnh án phạt kỷ lục tại EU vì hàng giả

Thế giới
(Baothanhhoa.vn) - Ủy ban châu Âu (EC) đã áp mức phạt kỷ lục 550 triệu euro (khoảng 629 triệu USD) đối với nền tảng AliExpress của “gã khổng lồ” thương mại điện tử Trung Quốc Alibaba, do không ngăn chặn hiệu quả việc rao bán các sản phẩm bất hợp pháp, hàng giả và hàng...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh